Country
Contract Development & Manufacturing Organizations in France
Strong sterile and biologics capacity in the heart of the EU. Compare EU-GMP French CDMOs across sterile manufacturing, biologics, and drug product — by capability and site.
92 companies listed
Manufacturing sites in France
The French CDMO landscape
France has the largest contract-manufacturing footprint in Europe after Germany, and a different shape to it. Where Germany's base skews toward API synthesis and biologics, France's centre of gravity is sterile and injectable production — vaccines, prefilled syringes, lyophilised product, complex injectables — alongside a long tail of oral-solid-dose plants originally built as captive sites for domestic pharma and later converted to contract work.
Manufacturing is overseen by the ANSM (Agence nationale de sécurité du médicament et des produits de santé), the national competent authority, whose inspectors issue the EU GMP certificates that are recognised across the Union. Most biologics and many complex products reach market through the EMA's centralised procedure rather than a national filing. France also carries a large share of Europe's FDA-inspected sites, a practical consequence of how much French capacity supplies the US market.
Reshoring is a live policy driver, not a slogan: successive French industrial programmes have put public money behind relocating production of medicines classed as strategically essential. For a sponsor, the near-term effect is that French sites have been investing in capacity and modernisation, and that a French CDMO conversation is often about securing an allocation rather than filling an empty suite.
Where French manufacturing actually happens
The Lyon corridor is France's densest life-science cluster, historically anchored in vaccines and in-vitro diagnostics and supported by the Lyonbiopôle competitiveness cluster. It concentrates biologics, vaccine, and sterile capacity, plus the analytical and regulatory service firms that grow up around them.
Alsace and the wider Grand Est, around Strasbourg, carry significant biologics and sterile manufacturing, benefiting from a cross-border labour market with Germany and Switzerland — a Basel-adjacent talent pool without Basel pricing.
Beyond those two, Île-de-France holds development-scale and clinical-supply capacity close to the research base, Normandy and Centre-Val de Loire hold large oral-solid-dose and sterile plants, and the south-west around Toulouse and Bordeaux adds further drug-product capacity. The practical implication is that French capacity is genuinely distributed — the right site depends on modality far more than on region.
Companies (92)
ABL (ABL, Inc. / ABL Europe)
France
AdhexPharma
France
AEC Partners
France
Aggrega Pharma, LLC
France
AI MegaLith (Megalith AI)
France
A
Ajay Europe Sarl (Ajay‑SQM)
France
Akkodis (Life Sciences & Healthcare)
France
Ascendio
France
A
Aspen Pharmacare (Aspen CDMO)
France
Astrea Pharma
France
ATEME
France
A
AUSY (Randstad Digital Engineering)
France
Axplora
France
Axyntis
France
Benta Lyon SAS
France
Biofarma S.p.A. (Biofarma Group)
France
Biopharma Group CDMO
France
Biopredic International
France
Bioprox SA (Bioprox Cultures / Bioprox Healthcare)
France
Biose Industrie
France
CARBOGEN AMCIS
France
Catalent Pharma Solution
France
CellEasy
France
CELLforCURE by SEQENS
France
Cenexi
France
C
Chemineau (Laboratoires Chemineau)
France
Cronos Premium
France
Curia Global, Inc.
France
Delpharm
France
Dishman Carbogen Amcis Ltd
France
Diverchim CDMO
France
Ethypharm
France
EUROAPI
France
Eurofins Biopharma Services (CDMO)
France
EUROPHARTECH
France
Euticals (now part of Curia)
France
Evotec
France
Fareva
France
F
FC FRANCE SAS (Farmacapsulas France)
France
F
Finabio
France
Flash BioSolutions
France
Genepep SAS
France
Gland Pharma
France
Groupe SYNERLAB CDMO
France
GTP Bioways
France
HTL Biotechnology
France
Indena
France
InovIntell
France
J
Just – Evotec Biologics
France
LFB Biomanufacturing
France
M2i Life Sciences
France
Meotec
France
Meribel Pharma Solutions
France
Minakem (Minafin Group)
France
Moehs Group
France
Naobios
France
NextPharma
France
NoDeV
France
NORCHIM (Norchim SAS)
France
Novartis Contract Manufacturing
France
Novasep
France
NT International
France
Nuvisan
France
O
Olon SpA
France
Only Orphans COTE
France
Oxford Biomedica (OXB)
France
Pharmatch
France
P
Pharmatis
France
Pierre Fabre (CDMO)
France
PMC Isochem (Isochem SAS, PMC Group)
France
PolyPeptide Group
France
ProteoGenix SAS
France
RD‑Biotech
France
Recipharm AB
France
Sanner GmbH
France
SB-PEPTIDE
France
Schneider Electric
France
SEQENS
France
Servier (Servier CDMO)
France
Sever Pharma Solutions
France
SGS
France
S
SK Pharmteco
France
Skyepharma Productions SAS
France
S
SQM‑Ajay (Ajay‑SQM Group)
France
Starlab Group
France
S
Sterigene
France
Thépenier Pharma & Cosmetics
France
U
Unither Pharmaceuticals
France
WeylChem
France
Yposkesi (an SK pharmteco company)
France
Z
Zach System (Zambon)
France
Z
Zambon
France
How this list is built: companies appear here when they have a manufacturing site in France in our facilities dataset and pass the marketplace eligibility gate (pharmaceutical contract manufacturers only — CROs, equipment suppliers, and other non-manufacturers are excluded). Read the full methodology for the eligibility gates and how our ranked lists are computed.
Frequently Asked Questions
How many CDMOs are in France?+
CDMO Hub lists a strong French roster — the live count and ranked list above are derived from verified manufacturing sites, reflecting genuine in-country production capacity.
What are French CDMOs strongest in?+
Sterile and injectable manufacturing above all — vaccines, prefilled syringes, lyophilised and complex injectables — plus biologics and a large oral-solid-dose base. Reshoring programmes for strategically essential medicines have added capacity and investment in recent years.
Who regulates pharmaceutical manufacturing in France?+
The ANSM (Agence nationale de sécurité du médicament et des produits de santé) is the national competent authority. It issues EU GMP certificates recognised across the European Union, while most biologics reach market via the EMA's centralised procedure. Many French sites also hold FDA registration — confirm the specific facility and product before contracting.
Where in France should I look for capacity?+
It depends on modality rather than geography alone. The Lyon corridor concentrates vaccines, biologics, and sterile capacity; Alsace and the Grand Est add biologics and sterile manufacturing with a cross-border talent pool; Île-de-France skews to development and clinical supply; Normandy and Centre-Val de Loire hold large oral-solid-dose and sterile plants.
Find the right CDMO in France
Our AI Matchmaker analyzes your project requirements and matches you with qualified France manufacturing partners. Free for buyers.